Suppression of experimental aortic aneurysms: Comparison of inducible nitric oxide synthase and cyclooxygenase inhibitors

Annals of Vascular Surgery

Volumn 19, Issue 2, 2005, Pages 248-257

  Armstrong, Peter J ^a   Franklin, David P ^a   Carey, David J ^a   Elmore, James R ^a,b  

^a WEIS CENTER FOR RESEARCH   (United States)

^b GEISINGER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; ELASTASE; ELASTIN; GELATINASE B; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR; ROFECOXIB; SODIUM CHLORIDE; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA ANEURYSM; ARTICLE; BLOOD PRESSURE MEASUREMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MODEL; DRUG ADMINISTRATION ROUTE; DRUG MECHANISM; DRUG SELECTIVITY; ENZYME INHIBITION; EVALUATION; EXPERIMENTAL MODEL; HEART RATE; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFUSION; INHIBITION KINETICS; LAVAGE; MALE; MEASUREMENT; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RANDOMIZATION; RAT; RNA ANALYSIS; STATISTICAL ANALYSIS; STOMACH; WESTERN BLOTTING;

EID: 18844374589     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10016-004-0174-7     Document Type: Article

References (42)

1. S Anidjar PB Dobin M Eichorst GP Graham G Chejfec 1992 Correlation of inflammatory infiltrate with the enlargement of experimental aortic aneurysms J Vasc Surg 16 139 147
2. JM Johanning PJ Armstrong DP Franklin DC Han DJ Carey JR Elmore 2002 Nitric oxide in experimental aneurysm formation: early events and consequences of nitric oxide inhibition Ann Vasc Surg 16 65 72
3. JM Johanning DP Franklin DC Han DJ Carey JR Elmore 2001 Inhibition of inducible nitric oxide synthase limits nitric oxide production and experimental aneurysm expansion J Vasc Surg 33 579 586
4. DR Holmes D Petrinec W Wester RW Thompson JM Reilly 1996 Indomethacin prevents elastase-induced abdominal aortic aneurysms in the rat J Surg Res 63 305 309
5. M Miralles W Wester GA Sicard R Thompson JM Reilly 1999 Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the cox2 isoform of cyclooxygenase J Vasc Surg 29 884 892
6. DR Holmes W Wester RW Thompson JM Reilly 1997 Prostaglandin E2 synthesis and cyclooxygenase expression in abdominal aortic aneurysms J Vasc Surg 25 810 815
7. DC Paik WG Ramey J Dillon MD Tilson 1997 The nitrite/elastin reaction: implications for in vivo degenerative effects Connect Tissue Res 36 24 51
8. DC Paik MD Tilson 1996 Neovascularization in the abdominal aortic aneurysm. Endothelial nitric oxide synthase, nitric oxide, and elastolysis Ann NY Acad Sci 18 800 877
9. GR Upchurch JW Ford SJ Weiss 2001 Nitric oxide inhibition increases matrix metalloproteinase-9 expression by rat aortic smooth muscle cells in vitro J Vasc Surg 34 76 83
10. EP Garvey JA Oplinger ES Furfine 1997 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo J Biol Chem 272 4959 4963
11. NS Buttar KK Wang 2000 The "aspirin" of the new millennium: cyclooxygenase-2 inhibitors Mayo Clin Proc 75 1027 1038
12. S Anidjar JL Salzmann D Gentric P Lagneau JP Camilleri JB Michel 1990 Elastase-induced experimental aneurysms in rats Circulation 82 973 981
13. DA Bigatel JR Elmore DJ Carey G Cizmeci-Smith DP Franklin JR Youkey 1999 The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms J Vasc Surg 29 130 138
14. CC Chan S Boyce S Brideau 1999 Rofecoxib (Vioxx, MK-0966; 4-(4′-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone(: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles J Pharmacol Exp Ther 290 551 560
15. K McMillan M Adler DS Auld 2000 Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry Proc Natl Acad Sci USA 97 1506 1511
16. G Parasher L Frenklakh DR Goodman T Siddiqui J Nandi RA Levine 2001 Nitric oxide inhibitors ameliorate indomethacin-induced enteropathy in rats Dig Dis Sci 46 2536 2541
17. LA Menchen AL Colon MA Mora 2001 N-(3-(aminomethyl) benzyl) acetamidine, an inducible nitric oxide synthase inhibitor, decreases colonic inflammation induced by trinitrobenzene sulphonic acid in rats Life Sci 69 479 491
18. GM Wray CG Millar CJ Hinds C Thiemermann 1998 Selective inhibition of the activity of inducible nitric oxide synthase prevents the circulatory failure, but not the organ injury/dysfunction, caused by endotoxin Shock 9 329 335
19. CG Carsten WC Calton JM Johanning 2001 Elastase is not sufficient to induce experimental abdominal aortic aneurysms J Vasc Surg 33 1255 1262
20. S Fukuda N Hashimoto H Naritomi 2000 Prevention of rat cerebral aneurysm formation by inhibition of nitric oxide synthase Circulation 101 2532 2538
21. JR Elmore BF Keister DP Franklin JR Youkey DJ Carey 1998 Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms Ann Vasc Surg 12 221 228
22. N Sakalihasan P Delvenne BV Nusgens R Limet CM Lapiere 1996 Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms J Vasc Surg 24 127 133
23. KM Newman J Jean-Claude L Hong 1994 Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysmal wall J Vasc Surg 20 814 820
24. D Petrinec S Liao DR Holmes JM Reilly WC Parks RW Thompson 1996 Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92kD gelatinase J Vasc Surg 23 336 346
25. G Moore S Liao JA Curci 1999 Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908) J Vasc Surg 29 522 532
26. RMF Wever TF Luscher F Cosentino TJ Rabelink 1998 Atherosclerosis and the two faces of endothelial nitric oxide synthase Circulation 97 108 112
27. AJ Maxwell PS Tsao JP Cooke 1998 Modulation of the nitric oxide synthase pathway in atherosclerosis Exp Physiol 83 573 584
28. M Hecker M Cattaruzza AH Wagner 1999 Regulation of inducible nitric oxide synthase gene expression in vascular smooth muscle cells Gen Pharmacol 32 9 16
29. N Hogg B Kalyanaraman 1999 Nitric oxide and lipid peroxidation Biochem Biophys Acta 141 378 384
30. G Luvara ME Pueyo M Philippe 1998 Chronic blockade of NO synthase activity induces a proinflammatory phenotype in the arterial wall: prevention by angiotensin II antagonism Arterioscler Thromb Vasc Biol 18 1408 1416
31. CS Baker RJ Hall TJ Evans 1999 Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages Arterioscler Thromb Vasc Biol 19 646 655
32. R Patel MG Attur M Dave SB Abramson AR Amin 1999 Regulation of cytosolic COX-2 and prostaglandin E2 production by nitric oxide in activated murine macrophages J Immunol 162 4191 4197
33. JS Luoma P Stralin SL Marklund TP Hiltunen T Sarkioja S Yla-Herttuala 1998 Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes charachteristic of oxidized LDL and peroxynitrate-modified proteins Arterioscler Thromb Vasc Biol 18 157 167
34. V Darley-Usmar B Halliwell 1996 Blood radicals: reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system Pharm Res 13 649 662
35. J Graves L Poston 1993 Beta-adrenoceptor agonist medicated relaxation of rat isolated resistance arteries: a role for the endothelium and nitric oxide Br J Pharmacol 108 631 637
36. AR Amin RN Patel GD Thakker CJ Lowenstein MG Attur SB Abramson 1997 Post-transcriptional regulation of inducible nitric oxide synthase mRNA in murine macrophages by doxycycline and chemically modified tetracyclines FEBS Lett 410 259 264
37. JK Lee M Borhani TL Ennis GR Upchurch Jr RW Thompson 2001 Experimental abdominal aortic aneurysms in mice lacking expression of inducible nitric oxide synthase Arterioscler Thromb Vasc Biol 21 1393 1401
38. AV Sterpetti A Cavallaro N Cavallari 1991 Factors influencing the rupture of abdominal aortic aneurysms Surg Gynecol Obstet 173 175 178
39. GR Gadowski DB Pilcher MA Ricci 1994 Abdominal aortic aneurysm expansion rate: effect of size and beta-adrenergic blockade J Vasc Surg 19 727 731
40. GR Gadowski MA Ricci ED Hendley DB Pilcher 1993 Hypertension accelerates the growth of experimental aortic aneurysms J Surg Res 54 431 436
41. MA Ricci JM Slaiby GR Gadowski ED Hendley P Nichols DB Pilcher 1996 Effects of hypertension and propranolol upon aneurysm expansion in the Anidjar/Dobrin aneurysm model Ann NY Acad Sci 800 89 96
42. PJ Kuhlencordt R Gyurko F Han 2001 Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice Circulation 104 448-454